CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression

Renato Franco, Gerardo Botti, Massimo Mascolo, Giovanna Loquercio, Giuseppina Liguori, Gennaro Ilardi, Simona Losito, Anna La Mura, Rosa Calemma, Caterina Ieranò, Jane Bryce, Crescenzo D'Alterio, Stefania Scala

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Despite improvements in early diagnosis of uveal melanoma, prognosis is still poor due to metastases development. Neoangiogenesis and migration are requisites to metastasis promotion. Cross-talking between CXCR4- CXCL12 axis and the VEGF pathway was shown to favours tumour progression. CXCR4-CXCL12-VEGF expression was evaluated by immunohistochemistry in 53 selected cases of primary uveal melanoma and in liver melanoma metastases. CXCR4 protein was detected in 41.4% cases, CXCL12 in 43.4% cases and VEGF expression in 39.6% cases. A significant correlation was found between CXCR4 and VEGF expression (p=0.011), CXCL12 and both tumour dimension and (p=0.006) and epithelioid-mixed cytotype (p=0.012). The two cases of uveal melanoma liver metastases in our series showed CXCR4 expression, weak immunoreactivity for CXCL12 and absent VEGF immunostaining. These data indicate that CXCR4-CXCL12 axis and its cross-talking with VEGF plays a role in uveal melanoma metastases and may be new prognostic markers in UMM. Moreover, these results suggest that targeted inhibition of CXCR4 could be introduced to control metastasis development in UMM.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalFrontiers in Bioscience - Elite
Volume2 E
Issue number1
Publication statusPublished - Jan 1 2010

Fingerprint

Vascular Endothelial Growth Factor A
Neoplasm Metastasis
Liver
Tumors
Uveal melanoma
Early Diagnosis
Melanoma
Neoplasms
Immunohistochemistry
Proteins

Keywords

  • CXCL12
  • CXCR4
  • Uveal Melanoma
  • VEGF

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Franco, R., Botti, G., Mascolo, M., Loquercio, G., Liguori, G., Ilardi, G., ... Scala, S. (2010). CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. Frontiers in Bioscience - Elite, 2 E(1), 13-21.

CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. / Franco, Renato; Botti, Gerardo; Mascolo, Massimo; Loquercio, Giovanna; Liguori, Giuseppina; Ilardi, Gennaro; Losito, Simona; La Mura, Anna; Calemma, Rosa; Ieranò, Caterina; Bryce, Jane; D'Alterio, Crescenzo; Scala, Stefania.

In: Frontiers in Bioscience - Elite, Vol. 2 E, No. 1, 01.01.2010, p. 13-21.

Research output: Contribution to journalArticle

Franco, R, Botti, G, Mascolo, M, Loquercio, G, Liguori, G, Ilardi, G, Losito, S, La Mura, A, Calemma, R, Ieranò, C, Bryce, J, D'Alterio, C & Scala, S 2010, 'CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression', Frontiers in Bioscience - Elite, vol. 2 E, no. 1, pp. 13-21.
Franco R, Botti G, Mascolo M, Loquercio G, Liguori G, Ilardi G et al. CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. Frontiers in Bioscience - Elite. 2010 Jan 1;2 E(1):13-21.
Franco, Renato ; Botti, Gerardo ; Mascolo, Massimo ; Loquercio, Giovanna ; Liguori, Giuseppina ; Ilardi, Gennaro ; Losito, Simona ; La Mura, Anna ; Calemma, Rosa ; Ieranò, Caterina ; Bryce, Jane ; D'Alterio, Crescenzo ; Scala, Stefania. / CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. In: Frontiers in Bioscience - Elite. 2010 ; Vol. 2 E, No. 1. pp. 13-21.
@article{5dbff433f80b44dd8b1b1072328d6308,
title = "CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression",
abstract = "Despite improvements in early diagnosis of uveal melanoma, prognosis is still poor due to metastases development. Neoangiogenesis and migration are requisites to metastasis promotion. Cross-talking between CXCR4- CXCL12 axis and the VEGF pathway was shown to favours tumour progression. CXCR4-CXCL12-VEGF expression was evaluated by immunohistochemistry in 53 selected cases of primary uveal melanoma and in liver melanoma metastases. CXCR4 protein was detected in 41.4{\%} cases, CXCL12 in 43.4{\%} cases and VEGF expression in 39.6{\%} cases. A significant correlation was found between CXCR4 and VEGF expression (p=0.011), CXCL12 and both tumour dimension and (p=0.006) and epithelioid-mixed cytotype (p=0.012). The two cases of uveal melanoma liver metastases in our series showed CXCR4 expression, weak immunoreactivity for CXCL12 and absent VEGF immunostaining. These data indicate that CXCR4-CXCL12 axis and its cross-talking with VEGF plays a role in uveal melanoma metastases and may be new prognostic markers in UMM. Moreover, these results suggest that targeted inhibition of CXCR4 could be introduced to control metastasis development in UMM.",
keywords = "CXCL12, CXCR4, Uveal Melanoma, VEGF",
author = "Renato Franco and Gerardo Botti and Massimo Mascolo and Giovanna Loquercio and Giuseppina Liguori and Gennaro Ilardi and Simona Losito and {La Mura}, Anna and Rosa Calemma and Caterina Ieran{\`o} and Jane Bryce and Crescenzo D'Alterio and Stefania Scala",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "2 E",
pages = "13--21",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression

AU - Franco, Renato

AU - Botti, Gerardo

AU - Mascolo, Massimo

AU - Loquercio, Giovanna

AU - Liguori, Giuseppina

AU - Ilardi, Gennaro

AU - Losito, Simona

AU - La Mura, Anna

AU - Calemma, Rosa

AU - Ieranò, Caterina

AU - Bryce, Jane

AU - D'Alterio, Crescenzo

AU - Scala, Stefania

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Despite improvements in early diagnosis of uveal melanoma, prognosis is still poor due to metastases development. Neoangiogenesis and migration are requisites to metastasis promotion. Cross-talking between CXCR4- CXCL12 axis and the VEGF pathway was shown to favours tumour progression. CXCR4-CXCL12-VEGF expression was evaluated by immunohistochemistry in 53 selected cases of primary uveal melanoma and in liver melanoma metastases. CXCR4 protein was detected in 41.4% cases, CXCL12 in 43.4% cases and VEGF expression in 39.6% cases. A significant correlation was found between CXCR4 and VEGF expression (p=0.011), CXCL12 and both tumour dimension and (p=0.006) and epithelioid-mixed cytotype (p=0.012). The two cases of uveal melanoma liver metastases in our series showed CXCR4 expression, weak immunoreactivity for CXCL12 and absent VEGF immunostaining. These data indicate that CXCR4-CXCL12 axis and its cross-talking with VEGF plays a role in uveal melanoma metastases and may be new prognostic markers in UMM. Moreover, these results suggest that targeted inhibition of CXCR4 could be introduced to control metastasis development in UMM.

AB - Despite improvements in early diagnosis of uveal melanoma, prognosis is still poor due to metastases development. Neoangiogenesis and migration are requisites to metastasis promotion. Cross-talking between CXCR4- CXCL12 axis and the VEGF pathway was shown to favours tumour progression. CXCR4-CXCL12-VEGF expression was evaluated by immunohistochemistry in 53 selected cases of primary uveal melanoma and in liver melanoma metastases. CXCR4 protein was detected in 41.4% cases, CXCL12 in 43.4% cases and VEGF expression in 39.6% cases. A significant correlation was found between CXCR4 and VEGF expression (p=0.011), CXCL12 and both tumour dimension and (p=0.006) and epithelioid-mixed cytotype (p=0.012). The two cases of uveal melanoma liver metastases in our series showed CXCR4 expression, weak immunoreactivity for CXCL12 and absent VEGF immunostaining. These data indicate that CXCR4-CXCL12 axis and its cross-talking with VEGF plays a role in uveal melanoma metastases and may be new prognostic markers in UMM. Moreover, these results suggest that targeted inhibition of CXCR4 could be introduced to control metastasis development in UMM.

KW - CXCL12

KW - CXCR4

KW - Uveal Melanoma

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=77954520823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954520823&partnerID=8YFLogxK

M3 - Article

C2 - 20036848

AN - SCOPUS:77954520823

VL - 2 E

SP - 13

EP - 21

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 1

ER -